Evidence map›Paper›PMID 38989968›Full record

ArticleJournal of homosexuality2025

Understanding Preferences for Visualized New and Future HIV Prevention Products Among Gay, Bisexual and Other Men Who Have Sex with Men in the Southern United States: A Mixed-Methods Study.

Damian J Denson, Ayana Stanley, Laura Randall, Casey Langer Tesfaye, Daniela Glusberg, Jessica Cardo, Adrian R King, Bryan Gale, Valerie Betley, Alisú Schoua-Glusberg and 1 more

Abstract read
In one paragraph

Article in Journal of homosexuality, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Damian J DensonDivision of HIV Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, GA, USA.ORCID 0000-0002-1643-4634
Ayana StanleyDivision of HIV Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, GA, USA.
Laura RandallResearch Support Services, Inc, Evanston, IL, USA.
Casey Langer TesfayeResearch Support Services, Inc, Evanston, IL, USA.
Daniela GlusbergResearch Support Services, Inc, Evanston, IL, USA.
Jessica CardoResearch Support Services, Inc, Evanston, IL, USA.
Adrian R KingResearch Support Services, Inc, Evanston, IL, USA.
Bryan GaleAmerican Institutes for Research, Inc, Rockville, MD, USA.
Valerie BetleyAmerican Institutes for Research, Inc, Rockville, MD, USA.
Alisú Schoua-GlusbergResearch Support Services, Inc, Evanston, IL, USA.
Paula M FrewEmory University School of Medicine, Department of Medicine, Division of Infectious Diseases, Atlanta, GA, USA.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Men who have sex with men (MSM) are vulnerable to HIV infection. Although daily oral pre-exposure prophylaxis (PrEP) prevents HIV among MSM, its usage remains low. We conducted virtual in-depth interviews (IDIs) and focus groups (FGs) with Black, Hispanic/Latino, and White MSM consisting of current PrEP users and those aware of but not currently using PrEP. We delved into their preferences regarding six emerging PrEP products: a weekly oral pill, event-driven oral pills, anal douche/enema, anal suppository, long-acting injection, and a skin implant. Our mixed methods analysis involved inductive content analysis of transcripts for thematic identification and calculations of preferences. Among the sample (

Indexed as

HIV InfectionsHomosexuality, MalePatient PreferencePre-Exposure ProphylaxisSexual and Gender MinoritiesAdultFocus GroupsHumansMaleMiddle AgedUnited StatesYoung AdultHIVHIV preventionMSMpre-exposure prophylaxisPrEP

Identifiers

PMID38989968
PMCPMC11724005

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.